Dave Bloom
CEO & Co-Founder of SnackSafely.com and proud food allergy dad.
Advocating for food allergy awareness and causes since the founding of SnackSafely.com in 2011. Dedicated to solving issues critical to the food allergy community by leveraging over 25 years of technical expertise gained serving various senior roles in the Financial Services industry.
Authority on issues regarding the manufacture of allergy-friendly food products and founder of the SnackSafely.com Manufacturer Partnership, a consortium of food manufacturers now numbering 75+ companies that have agreed to provide detailed disclosure of their manufacturing processes beyond what the FDA requires.
Symjepi, the Auto-Injector Alternative, to Launch Q1 2019
Prefilled syringe will join auto-injectors for emergency delivery of epinephrine.
It’s Here! The Safe Snack Guide Holiday 2018 Edition!
With an entire section devoted to allergy-friendly Christmas and Chanukkah treats for gifts and celebrations!
Did the Cost of a Left-Behind EpiPen Contribute to a Murder Confession?
Common knowledge that EpiPens are expensive may have tipped police off.
Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for Peanut Allergy
An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.
Teva Launches EpiPen Generic in US Priced at $300
Adult dose device available now in limited quantities with "Jr" dose available in the new year.
Study: Use Multiple Strategies to Safely Dine Out with Food Allergies
Diners who had reactions used fewer preventative strategies.
Parents Wonder Whether Epinephrine Would Have Saved Megan Lee’s Life
"If she’d had one, would things have turned out differently? We have no way of knowing but we’ve asked ourselves many times."
Study: Nearly Half of Adults with Food Allergies Reported An Onset After Age 18
Survey of over 40,000 adults shows adult onset of food allergies fairly common.
Study: Does Prior Administration of Epinephrine Adversely Impact Pediatric Anaphylaxis Patients?
Results support the use of 0.15 mg epinephrine auto-injectors in this population when lower-dose auto-injectors are unavailable.
Teaching Kids This is Funny Will Get Someone Hurt… or Worse
Don't be bigger asshats than your star. Take them down.
